{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T05:15:03Z","timestamp":1791350103339,"version":"4.3.1"},"reference-count":90,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2023,11,22]],"date-time":"2023-11-22T00:00:00Z","timestamp":1700611200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,11,22]],"date-time":"2023-11-22T00:00:00Z","timestamp":1700611200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Radiol"],"DOI":"10.1007\/s00330-023-10371-2","type":"journal-article","created":{"date-parts":[[2023,11,22]],"date-time":"2023-11-22T01:02:27Z","timestamp":1700614947000},"page":"3795-3812","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Assessment of arterial-phase hyperenhancement and late-phase washout of hepatocellular carcinoma\u2014a meta-analysis of contrast-enhanced ultrasound (CEUS) with SonoVue\u00ae and Sonazoid\u00ae"],"prefix":"10.1007","volume":"34","author":[{"given":"Jie","family":"Ren","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Fei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirko","family":"D\u00b4Onofrio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul S.","family":"Sidhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6015-6347","authenticated-orcid":false,"given":"Christoph F.","family":"Dietrich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,11,22]]},"reference":[{"key":"10371_CR1","doi-asserted-by":"crossref","unstructured":"Dietrich CF, Nols\u00f8e CP, Barr RG et al (2020) Guidelines and Good Clinical Practice Recommendations for Contrast-Enhanced Ultrasound (CEUS) in the Liver-Update 2020 WFUMB in Cooperation with EFSUMB, AFSUMB, AIUM, and FLAUS. Ultrasound Med Biol 46:2579\u20132604","DOI":"10.1016\/j.ultrasmedbio.2020.04.030"},{"key":"10371_CR2","doi-asserted-by":"crossref","unstructured":"Dietrich CF, Nols\u00f8e CP, Barr RG et al (2020) Guidelines and Good Clinical Practice Recommendations for Contrast Enhanced Ultrasound (CEUS) in the Liver - Update 2020 - WFUMB in Cooperation with EFSUMB, AFSUMB, AIUM, and FLAUS. Ultraschall Med 41:562\u2013585","DOI":"10.1055\/a-1177-0530"},{"key":"10371_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ultrasmedbio.2018.06.015","volume":"45","author":"CF Dietrich","year":"2019","unstructured":"Dietrich CF, Tannapfel A, Jang HJ, Kim TK, Burns PN, Dong Y (2019) Ultrasound imaging of hepatocellular adenoma using the new histology classification. Ultrasound Med Biol 45:1\u201310","journal-title":"Ultrasound Med Biol"},{"key":"10371_CR4","doi-asserted-by":"crossref","unstructured":"Kono Y, Lyshchik A, Cosgrove D et al (2017) Contrast enhanced ultrasound (CEUS) Liver Imaging Reporting and Data System (LI-RADI)): the official version by the American College of Radiology (ACR). Ultraschall Med 38:85\u201386","DOI":"10.1055\/s-0042-124369"},{"key":"10371_CR5","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1002\/hep.21615","volume":"45","author":"CF Dietrich","year":"2007","unstructured":"Dietrich CF, Mertens JC, Braden B, Schuessler G, Ott M, Ignee A (2007) Contrast-enhanced ultrasound of histologically proven liver hemangiomas. Hepatology 45:1139\u20131145","journal-title":"Hepatology"},{"key":"10371_CR6","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1259\/bjr\/88181612","volume":"78","author":"CF Dietrich","year":"2005","unstructured":"Dietrich CF, Schuessler G, Trojan J, Fellbaum C, Ignee A (2005) Differentiation of focal nodular hyperplasia and hepatocellular adenoma by contrast-enhanced ultrasound. Br J Radiol 78:704\u2013707","journal-title":"Br J Radiol"},{"key":"10371_CR7","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/j.ultrasmedbio.2006.08.008","volume":"33","author":"K Yanagisawa","year":"2007","unstructured":"Yanagisawa K, Moriyasu F, Miyahara T, Yuki M, Iijima H (2007) Phagocytosis of ultrasound contrast agent microbubbles by Kupffer cells. Ultrasound Med Biol 33:318\u2013325","journal-title":"Ultrasound Med Biol"},{"key":"10371_CR8","doi-asserted-by":"crossref","unstructured":"Mita K, Kim SR, Kudo M et al (2010) Diagnostic sensitivity of imaging modalities for hepatocellular carcinoma smaller than 2 cm. World J Gastroenterol 16:4187\u20134192","DOI":"10.3748\/wjg.v16.i33.4187"},{"key":"10371_CR9","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1148\/radiol.2020200115","volume":"297","author":"HJ Kang","year":"2020","unstructured":"Kang HJ, Lee JM, Yoon JH, Lee K, Kim H, Han JK (2020) Contrast-enhanced US with sulfur hexafluoride and perfluorobutane for the diagnosis of hepatocellular carcinoma in individuals with high risk. Radiology 297:108\u2013116","journal-title":"Radiology"},{"key":"10371_CR10","doi-asserted-by":"crossref","unstructured":"Whiting PF, Rutjes AW, Westwood ME et al (2011) QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med 155:529\u2013536","DOI":"10.7326\/0003-4819-155-8-201110180-00009"},{"key":"10371_CR11","doi-asserted-by":"publisher","first-page":"354","DOI":"10.3348\/kjr.2020.0973","volume":"22","author":"HJ Kang","year":"2021","unstructured":"Kang HJ, Lee JM, Yoon JH, Han JK (2021) Role of contrast-enhanced ultrasound as a second-line diagnostic modality in noninvasive diagnostic algorithms for hepatocellular carcinoma. Korean J Radiol 22:354\u2013365","journal-title":"Korean J Radiol"},{"key":"10371_CR12","doi-asserted-by":"crossref","unstructured":"Li S, Zhou L, Chen R et al (2021) Diagnostic efficacy of contrast-enhanced ultrasound versus MRI Liver Imaging Reporting and Data System (LI-RADS) for categorising hepatic observations in patients at risk of hepatocellular carcinoma. Clin Radiol 76:161 e161-161 e110","DOI":"10.1016\/j.crad.2020.10.009"},{"key":"10371_CR13","doi-asserted-by":"crossref","unstructured":"Schellhaas B, Bernatik T, Dirks K et al (2021) Contrast-enhanced ultrasound patterns for the non-invasive diagnosis of hepatocellular carcinoma: a prospective multicenter study in histologically proven liver lesions in a real-life setting demonstrating the benefit of extended late phase observation. Ultrasound Med Biol 47:3170\u20133180","DOI":"10.1016\/j.ultrasmedbio.2021.07.010"},{"key":"10371_CR14","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1016\/j.ultrasmedbio.2021.01.020","volume":"47","author":"Z Huang","year":"2021","unstructured":"Huang Z, Zhou P, Li S, Li K (2021) MR versus CEUS LI-RADS for distinguishing hepatocellular carcinoma from other hepatic malignancies in high-risk patients. Ultrasound Med Biol 47:1244\u20131252","journal-title":"Ultrasound Med Biol"},{"key":"10371_CR15","doi-asserted-by":"crossref","unstructured":"Cheng MQ, Hu HT, Huang H et al (2021) Pathological considerations of CEUS LI-RADS: correlation with fibrosis stage and tumour histological grade. Eur Radiol 31:5680\u20135688","DOI":"10.1007\/s00330-020-07660-5"},{"key":"10371_CR16","doi-asserted-by":"crossref","unstructured":"Tan Y, Xie XY, Li XJ et al (2020) Comparison of hepatic epithelioid angiomyolipoma and non-hepatitis B, non-hepatitis C hepatocellular carcinoma on contrast-enhanced ultrasound. Diagn Interv Imaging 101:733\u2013738","DOI":"10.1016\/j.diii.2020.03.005"},{"key":"10371_CR17","doi-asserted-by":"crossref","unstructured":"Huang JY, Li JW, Lu Q et al (2020) Diagnostic accuracy of CEUS LI-RADS for the characterization of liver nodules 20 mm or smaller in patients at risk for hepatocellular carcinoma. Radiology 294:329\u2013339","DOI":"10.1148\/radiol.2019191086"},{"key":"10371_CR18","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1002\/jum.15242","volume":"39","author":"JY Wang","year":"2020","unstructured":"Wang JY, Feng SY, Xu JW, Li J, Chu L, Cui XW, Dietrich CF (2020) Usefulness of the contrast-enhanced ultrasound Liver Imaging Reporting and Data System in diagnosing focal liver lesions by inexperienced radiologists. J Ultrasound Med 39:1537\u20131546","journal-title":"J Ultrasound Med"},{"key":"10371_CR19","doi-asserted-by":"crossref","unstructured":"Zhou J, Sun H, Wang Z et al (2020) Guidelines for the Diagnosis and Treatment of Hepatocellular Carcinoma.\u00a0Liver Cancer 9:682\u2013720","DOI":"10.1159\/000509424"},{"key":"10371_CR20","doi-asserted-by":"publisher","first-page":"356","DOI":"10.14366\/usg.19093","volume":"39","author":"HC Zhang","year":"2020","unstructured":"Zhang HC, Zhu T, Hu RF, Wu L (2020) Contrast-enhanced ultrasound imaging features and clinical characteristics of combined hepatocellular cholangiocarcinoma: comparison with hepatocellular carcinoma and cholangiocarcinoma. Ultrasonography 39:356\u2013366","journal-title":"Ultrasonography"},{"key":"10371_CR21","doi-asserted-by":"crossref","unstructured":"Duan Y, Xie X, Li Q et al (2020) Differentiation of regenerative nodule, dysplastic nodule, and small hepatocellular carcinoma in cirrhotic patients: a contrast-enhanced ultrasound-based multivariable model analysis. Eur Radiol 30:4741\u20134751","DOI":"10.1007\/s00330-020-06834-5"},{"key":"10371_CR22","doi-asserted-by":"publisher","first-page":"1799","DOI":"10.1002\/jum.15288","volume":"39","author":"PL Fan","year":"2020","unstructured":"Fan PL, Xia HS, Ding H, Dong Y, Chen LL, Wang WP (2020) Characterization of early hepatocellular carcinoma and high-grade dysplastic nodules on contrast-enhanced ultrasound: correlation with histopathologic findings. J Ultrasound Med 39:1799\u20131808","journal-title":"J Ultrasound Med"},{"key":"10371_CR23","doi-asserted-by":"publisher","first-page":"109341","DOI":"10.1016\/j.ejrad.2020.109341","volume":"132","author":"PL Fan","year":"2020","unstructured":"Fan PL, Ding H, Mao F, Chen LL, Dong Y, Wang WP (2020) Enhancement patterns of small hepatocellular carcinoma (<\/= 30 mm) on contrast-enhanced ultrasound: correlation with clinicopathologic characteristics. Eur J Radiol 132:109341","journal-title":"Eur J Radiol"},{"key":"10371_CR24","doi-asserted-by":"crossref","unstructured":"Chen LD, Ruan SM, Lin Y et al (2019) Comparison between M-score and LR-M in the reporting system of contrast-enhanced ultrasound LI-RADS. Eur Radiol 29:4249\u20134257","DOI":"10.1007\/s00330-018-5927-8"},{"key":"10371_CR25","doi-asserted-by":"crossref","unstructured":"Terzi E, Iavarone M, Pompili M et al (2018) Contrast ultrasound LI-RADS LR-5 identifies hepatocellular carcinoma in cirrhosis in a multicenter restropective study of 1,006 nodules. J Hepatol 68:485\u2013492","DOI":"10.1016\/j.jhep.2017.11.007"},{"key":"10371_CR26","doi-asserted-by":"publisher","first-page":"e12781","DOI":"10.1097\/MD.0000000000012781","volume":"97","author":"SK Shin","year":"2018","unstructured":"Shin SK, Choi DJ, Kim JH, Kim YS, Kwon OS (2018) Characteristics of contrast-enhanced ultrasound in distinguishing small (<\/=3 cm) hepatocellular carcinoma from intrahepatic cholangiocarcinoma. Medicine (Baltimore) 97:e12781","journal-title":"Medicine (Baltimore)"},{"key":"10371_CR27","doi-asserted-by":"crossref","unstructured":"Yang D, Li R, Zhang XH et al (2018) Perfusion characteristics of hepatocellular carcinoma at contrast-enhanced ultrasound: influence of the cellular differentiation, the tumor size and the underlying hepatic condition. Sci Rep 8:4713","DOI":"10.1038\/s41598-018-23007-z"},{"key":"10371_CR28","doi-asserted-by":"publisher","first-page":"8970156","DOI":"10.1155\/2017\/8970156","volume":"2017","author":"Y Dong","year":"2017","unstructured":"Dong Y, Mao F, Cao J, Fan P, Wang WP (2017) Characterization of focal liver lesions indistinctive on B mode ultrasound: benefits of contrast-enhanced ultrasound. Biomed Res Int 2017:8970156","journal-title":"Biomed Res Int"},{"key":"10371_CR29","doi-asserted-by":"crossref","unstructured":"Jin C, Zhang XY, Li JW et al (2017) Impact of tumor size and cirrhotic background for differentiating HCC and ICC with CEUS: does it matter for patients undergoing hepatectomy? Oncotarget 8:83698\u201383711","DOI":"10.18632\/oncotarget.19624"},{"key":"10371_CR30","doi-asserted-by":"crossref","unstructured":"Moudgil S, Kalra N, Prabhakar N et al (2017) Comparison of contrast enhanced ultrasound with contrast enhanced computed tomography for the diagnosis of hepatocellular carcinoma. J Clin Exp Hepatol 7:222\u2013229","DOI":"10.1016\/j.jceh.2017.03.003"},{"key":"10371_CR31","doi-asserted-by":"crossref","unstructured":"Schellhaas B, Wildner D, Pfeifer L et al (2016) LI-RADS-CEUS - proposal for a contrast-enhanced ultrasound algorithm for the diagnosis of hepatocellular carcinoma in high-risk populations. Ultraschall Med 37:627\u2013634","DOI":"10.1055\/s-0042-112221"},{"key":"10371_CR32","doi-asserted-by":"crossref","unstructured":"Liu J, Wang D, Li H et al (2015) Clinical value of contrast-enhanced ultrasound in diagnosis of hyperechoic liver lesions. Med Sci Monit 21:2845\u20132850","DOI":"10.12659\/MSM.894115"},{"key":"10371_CR33","unstructured":"Liu JJ, Li HX, Chen ZB et al (2015) Consistency analysis of contrast-enhanced ultrasound and contrast-enhanced CT in diagnosis of small hepatocellular carcinoma. Int J Clin Exp Med 8:21466\u201321471"},{"key":"10371_CR34","unstructured":"Wu W, Chen M, Yan K et al (2015) Evaluation of contrast-enhanced ultrasound for diagnosis of dysplastic nodules with a focus of hepatocellular carcinoma in liver cirrhosis patients. Chin J Cancer Res 27:83\u201389"},{"key":"10371_CR35","doi-asserted-by":"crossref","unstructured":"Liu GJ, Wang W, Lu MD et al (2015) Contrast-enhanced ultrasound for the characterization of hepatocellular carcinoma and intrahepatic cholangiocarcinoma. Liver Cancer 4:241\u2013252","DOI":"10.1159\/000367738"},{"key":"10371_CR36","doi-asserted-by":"crossref","unstructured":"de Sio I, Iadevaia MD, Vitale LM et al (2014) Optimized contrast-enhanced ultrasonography for characterization of focal liver lesions in cirrhosis: a single-center retrospective study.\u00a0United European Gastroenterol J\u00a02:279\u2013287","DOI":"10.1177\/2050640614538964"},{"key":"10371_CR37","doi-asserted-by":"crossref","unstructured":"D'Onofrio M, Crosara S, De Robertis R et al (2014) Malignant focal liver lesions at contrast-enhanced ultrasonography and magnetic resonance with hepatospecific contrast agent. Ultrasound 22:91\u201398","DOI":"10.1177\/1742271X13513888"},{"key":"10371_CR38","doi-asserted-by":"crossref","unstructured":"Li R, Yuan MX, Ma KS et al (2014) Detailed analysis of temporal features on contrast enhanced ultrasound may help differentiate intrahepatic cholangiocarcinoma from hepatocellular carcinoma in cirrhosis.\u00a0PLoS One\u00a09:e98612","DOI":"10.1371\/journal.pone.0098612"},{"key":"10371_CR39","doi-asserted-by":"crossref","unstructured":"Pei XQ, Liu LZ, Xiong YH et al (2013) Quantitative analysis of contrast-enhanced ultrasonography: differentiating focal nodular hyperplasia from hepatocellular carcinoma. Br J Radiol 86:20120536","DOI":"10.1259\/bjr.20120536"},{"key":"10371_CR40","doi-asserted-by":"crossref","unstructured":"Xu HX, Lu MD, Liu LN et al (2012) Discrimination between neoplastic and non-neoplastic lesions in cirrhotic liver using contrast-enhanced ultrasound. Br J Radiol 85:1376\u20131384","DOI":"10.1259\/bjr\/19932596"},{"key":"10371_CR41","first-page":"236","volume":"7","author":"A Martie","year":"2012","unstructured":"Martie A, Sporea I, Sirli R, Popescu A, Danila M (2012) How often hepatocellular carcinoma has a typical pattern in contrast enhanced ultrasound? Maedica (Bucur) 7:236\u2013240","journal-title":"Maedica (Bucur)"},{"key":"10371_CR42","unstructured":"Giorgio A, Calisti G, di Sarno A et al (2011) Characterization of dysplastic nodules, early hepatocellular carcinoma and progressed hepatocellular carcinoma in cirrhosis with contrast-enhanced ultrasound. Anticancer Res 31:3977\u20133982"},{"key":"10371_CR43","doi-asserted-by":"crossref","unstructured":"Leoni S, Piscaglia F, Golfieri R et al (2010) The impact of vascular and nonvascular findings on the noninvasive diagnosis of small hepatocellular carcinoma based on the EASL and AASLD criteria. Am J Gastroenterol 105:599\u2013609","DOI":"10.1038\/ajg.2009.654"},{"key":"10371_CR44","doi-asserted-by":"crossref","unstructured":"Xu HX, Xie XY, Lu MD et al (2008) Contrast-enhanced sonography in the diagnosis of small hepatocellular carcinoma < or =2 cm. J Clin Ultrasound 36:257\u2013266","DOI":"10.1002\/jcu.20433"},{"key":"10371_CR45","doi-asserted-by":"crossref","unstructured":"Forner A, Vilana R, Ayuso C et al (2008) Diagnosis of hepatic nodules 20 mm or smaller in cirrhosis: prospective validation of the noninvasive diagnostic criteria for hepatocellular carcinoma. Hepatology 47:97\u2013104","DOI":"10.1002\/hep.21966"},{"key":"10371_CR46","doi-asserted-by":"crossref","unstructured":"Quaia E, D'Onofrio M, Cabassa P et al (2007) Diagnostic value of hepatocellular nodule vascularity after microbubble injection for characterizing malignancy in patients with cirrhosis. AJR Am J Roentgenol 189:1474\u20131483","DOI":"10.2214\/AJR.07.2122"},{"key":"10371_CR47","unstructured":"Giorgio A, De Stefano G, Coppola C et al (2007) Contrast-enhanced sonography in the characterization of small hepatocellular carcinomas in cirrhotic patients: comparison with contrast-enhanced ultrafast magnetic resonance imaging. Anticancer Res 27:4263\u20134269"},{"key":"10371_CR48","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1002\/jcu.20234","volume":"34","author":"HXLG Xu","year":"2006","unstructured":"Xu HXLG, Lu MD, Xie XY, Xu ZF, Zheng YL, Liang JY (2006) Characterization of focal liver lesions using contrast-enhanced sonography with a low mechanical index mode and a sulfur hexafluoride-filled microbubble contrast agent. J Clin Ultrasound 34:261\u2013272","journal-title":"J Clin Ultrasound"},{"key":"10371_CR49","doi-asserted-by":"crossref","unstructured":"Liu GJ, Xu HX, Lu MD et al (2006) Enhancement pattern of hepatocellular carcinoma: comparison of real-time contrast-enhanced ultrasound and contrast-enhanced computed tomography. Clin Imaging 30:315\u2013321","DOI":"10.1016\/j.clinimag.2006.03.031"},{"key":"10371_CR50","doi-asserted-by":"crossref","unstructured":"Gaiani S, Celli N, Piscaglia F et al (2004) Usefulness of contrast-enhanced perfusional sonography in the assessment of hepatocellular carcinoma hypervascular at spiral computed tomography. J Hepatol 41:421\u2013426","DOI":"10.1016\/j.jhep.2004.04.022"},{"key":"10371_CR51","doi-asserted-by":"crossref","unstructured":"Giorgio A, Ferraioli G, Tarantino L et al (2004) Contrast-enhanced sonographic appearance of hepatocellular carcinoma in patients with cirrhosis: comparison with contrast-enhanced helical CT appearance. AJR Am J Roentgenol 183:1319\u20131326","DOI":"10.2214\/ajr.183.5.1831319"},{"key":"10371_CR52","doi-asserted-by":"crossref","unstructured":"Wang F, Numata K, Chuma M et al (2001) A study on the inconsistency of arterial phase hypervascularity detection between contrast-enhanced ultrasound using sonazoid and gadolinium-ethoxybenzyl-diethylenetriamine penta-acetic acid magnetic resonance imaging of hepatocellular carcinoma lesions. J Med Ultrason 2021(48):215\u2013224","DOI":"10.1007\/s10396-021-01086-2"},{"key":"10371_CR53","doi-asserted-by":"crossref","unstructured":"Wang F, Numata K, Okada M et al (2021) Comparison of Sonazoid contrast-enhanced ultrasound and gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid MRI for the histological diagnosis of hepatocellular carcinoma. Quant Imaging Med Surg 11:2521\u20132540","DOI":"10.21037\/qims-20-685"},{"key":"10371_CR54","doi-asserted-by":"publisher","first-page":"486","DOI":"10.14366\/usg.20120","volume":"40","author":"JA Hwang","year":"2021","unstructured":"Hwang JA, Jeong WK, Min JH, Kim YY, Heo NH, Lim HK (2021) Sonazoid-enhanced ultrasonography: comparison with CT\/MRI Liver Imaging Reporting and Data System in patients with suspected hepatocellular carcinoma. Ultrasonography 40:486\u2013498","journal-title":"Ultrasonography"},{"key":"10371_CR55","doi-asserted-by":"crossref","unstructured":"Sugimoto K, Kakegawa T, Takahashi H et al (2020) Usefulness of modified CEUS LI-RADS for the diagnosis of hepatocellular carcinoma using sonazoid. Diagnostics (Basel) 10:828\u2013841","DOI":"10.3390\/diagnostics10100828"},{"key":"10371_CR56","doi-asserted-by":"publisher","first-page":"319","DOI":"10.35772\/ghm.2020.01092","volume":"2","author":"A Saito","year":"2020","unstructured":"Saito A, Yamamoto M, Katagiri S, Yamashita S, Nakano M, Morizane T (2020) Early hemodynamics of hepatocellular carcinoma using contrast-enhanced ultrasound with Sonazoid: focus on the pure arterial and early portal phases. Glob Health Med 2:319\u2013327","journal-title":"Glob Health Med"},{"key":"10371_CR57","doi-asserted-by":"crossref","unstructured":"Wang F, Numata K, Nakano M et al (2020) Diagnostic value of imaging methods in the histological four grading of hepatocellular carcinoma. Diagnostics (Basel) 10:321\u2013340","DOI":"10.3390\/diagnostics10050321"},{"key":"10371_CR58","doi-asserted-by":"crossref","unstructured":"Duisyenbi Z, Numata K, Nihonmatsu H et al (2019) Comparison between low mechanical index and high mechanical index contrast modes of contrast-enhanced ultrasonography: evaluation of perfusion defects of hypervascular hepatocellular carcinomas during the post-vascular phase. J Ultrasound Med 38:2329\u20132338","DOI":"10.1002\/jum.14926"},{"issue":"45","key":"10371_CR59","first-page":"223","volume":"2018","author":"K Murata","year":"2001","unstructured":"Murata K, Saito A, Katagiri S, Ariizumi S, Nakano M, Yamamoto M (2001) Association of des-gamma-carboxy prothrombin production and Sonazoid-enhanced ultrasound findings in hepatocellular carcinomas of different histologic grades. J Med Ultrason 2018(45):223\u2013229","journal-title":"J Med Ultrason"},{"key":"10371_CR60","doi-asserted-by":"crossref","unstructured":"Takada H, Tsuchiya K, Yasui Y et al (2016) Irregular vascular pattern by contrast-enhanced ultrasonography and high serum Lens culinaris agglutinin-reactive fraction of alpha-fetoprotein level predict poor outcome after successful radiofrequency ablation in patients with early-stage hepatocellular carcinoma. Cancer Med 5:3111\u20133120","DOI":"10.1002\/cam4.932"},{"key":"10371_CR61","doi-asserted-by":"publisher","first-page":"423","DOI":"10.7863\/ultra.34.3.423","volume":"34","author":"K Suzuki","year":"2015","unstructured":"Suzuki K, Okuda Y, Ota M, Kojima F, Horimoto M (2015) Diagnosis of hepatocellular carcinoma nodules in patients with chronic liver disease using contrast-enhanced sonography: usefulness of the combination of arterial- and Kupffer-phase enhancement patterns. J Ultrasound Med 34:423\u2013433","journal-title":"J Ultrasound Med"},{"key":"10371_CR62","doi-asserted-by":"crossref","unstructured":"Tada T, Kumada T, Toyoda H et al (2015) Utility of contrast-enhanced ultrasonography with perflubutane for determining histologic grade in hepatocellular carcinoma. Ultrasound Med Biol 41:3070\u20133078","DOI":"10.1016\/j.ultrasmedbio.2015.07.023"},{"key":"10371_CR63","doi-asserted-by":"crossref","unstructured":"Sugimoto K, Kim SR, Imoto S et al (2015) Characteristics of hypovascular versus hypervascular well-differentiated hepatocellular carcinoma smaller than 2 cm - focus on tumor size, markers and imaging detectability. Dig Dis 33:721\u2013727","DOI":"10.1159\/000439078"},{"key":"10371_CR64","doi-asserted-by":"crossref","unstructured":"Ohama H, Imai Y, Nakashima O et al (2014) Images of Sonazoid-enhanced ultrasonography in multistep hepatocarcinogenesis: comparison with Gd-EOB-DTPA-enhanced MRI. J Gastroenterol 49:1081\u20131093","DOI":"10.1007\/s00535-013-0859-1"},{"key":"10371_CR65","doi-asserted-by":"crossref","unstructured":"Tanaka H, Iijima H, Higashiura A et al (2014) New malignant grading system for hepatocellular carcinoma using the Sonazoid contrast agent for ultrasonography. J Gastroenterol 49:755\u2013763","DOI":"10.1007\/s00535-013-0830-1"},{"key":"10371_CR66","doi-asserted-by":"crossref","unstructured":"Takahashi M, Maruyama H, Shimada T et al (2013) Characterization of hepatic lesions (<\/= 30 mm) with liver-specific contrast agents: a comparison between ultrasound and magnetic resonance imaging. Eur J Radiol 82:75\u201384","DOI":"10.1016\/j.ejrad.2012.05.035"},{"key":"10371_CR67","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1259\/bjr\/20440141","volume":"85","author":"H Maruyama","year":"2012","unstructured":"Maruyama H, Takahashi M, Ishibashi H, Yoshikawa M, Yokosuka O (2012) Contrast-enhanced ultrasound for characterisation of hepatic lesions appearing non-hypervascular on CT in chronic liver diseases. Br J Radiol 85:351\u2013357","journal-title":"Br J Radiol"},{"key":"10371_CR68","doi-asserted-by":"crossref","unstructured":"Maruyama H, Takahashi M, Sekimoto T et al (2012) Heterogeneity of microbubble accumulation: a novel approach to discriminate between well-differentiated hepatocellular carcinomas and regenerative nodules. Ultrasound Med Biol 38:383\u2013388","DOI":"10.1016\/j.ultrasmedbio.2011.12.006"},{"key":"10371_CR69","doi-asserted-by":"crossref","unstructured":"Goto E, Masuzaki R, Tateishi R et al (2012) Value of post-vascular phase (Kupffer imaging) by contrast-enhanced ultrasonography using Sonazoid in the detection of hepatocellular carcinoma. J Gastroenterol 47:477\u2013485","DOI":"10.1007\/s00535-011-0512-9"},{"key":"10371_CR70","doi-asserted-by":"crossref","unstructured":"Alaboudy A, Inoue T, Hatanaka K et al (2011) Usefulness of combination of imaging modalities in the diagnosis of hepatocellular carcinoma using Sona\u00aed(R)-enhanced ultrasound, gadolinium diethylene-triamine-pentaacetic acid-enhanced magnetic resonance imaging, and contrast-enhanced computed tomography. Oncology 81(Suppl 1):66\u201372","DOI":"10.1159\/000333264"},{"key":"10371_CR71","doi-asserted-by":"crossref","unstructured":"Mandai M, Koda M, Matono T et al (2011) Assessment of hepatocellular carcinoma by contrast-enhanced ultrasound with perfluorobutane microbubbles: comparison with dynamic CT. Br J Radiol 84:499\u2013507","DOI":"10.1259\/bjr\/38682601"},{"key":"10371_CR72","doi-asserted-by":"publisher","first-page":"W123","DOI":"10.2214\/AJR.10.4242","volume":"196","author":"M Takahashi","year":"2011","unstructured":"Takahashi M, Maruyama H, Ishibashi H, Yoshikawa M, Yokosuka O (2011) Contrast-enhanced ultrasound with perflubutane microbubble agent: evaluation of differentiation of hepatocellular carcinoma. AJR Am J Roentgenol 196:W123-131","journal-title":"AJR Am J Roentgenol"},{"issue":"37","key":"10371_CR73","first-page":"167","volume":"2010","author":"S Patel","year":"2001","unstructured":"Patel S, Saito A, Yoneda Y, Hayano T, Shiratori K (2001) Comparing enhancement and washout patterns of hepatic lesions between sonazoid-enhanced ultrasound and contrast-enhanced computed tomography. J Med Ultrason 2010(37):167\u2013173","journal-title":"J Med Ultrason"},{"key":"10371_CR74","doi-asserted-by":"crossref","unstructured":"Luo W, Numata K, Morimoto M et al (2010) Differentiation of focal liver lesions using three-dimensional ultrasonography: retrospective and prospective studies. World J Gastroenterol 16:2109\u20132119","DOI":"10.3748\/wjg.v16.i17.2109"},{"key":"10371_CR75","doi-asserted-by":"publisher","first-page":"e102","DOI":"10.1016\/j.ejrad.2009.08.017","volume":"75","author":"H Maruyama","year":"2010","unstructured":"Maruyama H, Takahashi M, Ishibashi H, Okabe S, Yoshikawa M, Yokosuka O (2010) Changes in tumor vascularity precede microbubble contrast accumulation deficit in the process of dedifferentiation of hepatocellular carcinoma. Eur J Radiol 75:e102-106","journal-title":"Eur J Radiol"},{"key":"10371_CR76","doi-asserted-by":"crossref","unstructured":"Kawada N, Ohkawa K, Tanaka S et al (2010) Improved diagnosis of well-differentiated hepatocellular carcinoma with gadolinium ethoxybenzyl diethylene triamine pentaacetic acid-enhanced magnetic resonance imaging and Sonazoid contrast-enhanced ultrasonography. Hepatol Res 40:930\u2013936","DOI":"10.1111\/j.1872-034X.2010.00697.x"},{"key":"10371_CR77","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1007\/s00535-009-0053-7","volume":"44","author":"K Korenaga","year":"2009","unstructured":"Korenaga K, Korenaga M, Furukawa M, Yamasaki T, Sakaida I (2009) Usefulness of Sonazoid contrast-enhanced ultrasonography for hepatocellular carcinoma: comparison with pathological diagnosis and superparamagnetic iron oxide magnetic resonance images. J Gastroenterol 44:733\u2013741","journal-title":"J Gastroenterol"},{"key":"10371_CR78","doi-asserted-by":"crossref","unstructured":"Luo W, Numata K, Morimoto M et al (2009) Clinical utility of contrast-enhanced three-dimensional ultrasound imaging with Sonazoid: findings on hepatocellular carcinoma lesions. Eur J Radiol 72:425\u2013431","DOI":"10.1016\/j.ejrad.2008.09.003"},{"key":"10371_CR79","doi-asserted-by":"crossref","unstructured":"Inoue T, Kudo M, Hatanaka K et al (2008) Imaging of hepatocellular carcinoma: qualitative and quantitative analysis of postvascular phase contrastenhanced ultrasonography with sonazoid. Comparison with superparamagnetic iron oxide magnetic resonance images. Oncology 75(Suppl 1):48\u201354","DOI":"10.1159\/000173424"},{"key":"10371_CR80","doi-asserted-by":"crossref","unstructured":"Marrero JA, Kulik LM, Sirlin CB et al (2018) Diagnosis, staging, and management of hepatocellular carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases. Hepatology 68:723\u2013750","DOI":"10.1002\/hep.29913"},{"key":"10371_CR81","doi-asserted-by":"crossref","unstructured":"Kokudo N, Takemura N, Hasegawa K et al (2019) Clinical practice guidelines for hepatocellular carcinoma: The Japan Society of Hepatology 2017 (4th JSH-HCC guidelines) 2019 update. Hepatol Res 49:1109\u20131113","DOI":"10.1111\/hepr.13411"},{"key":"10371_CR82","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.jhep.2018.03.019","volume":"69","author":"European Association for the Study of the Liver","year":"2018","unstructured":"European Association for the Study of the Liver (2018) Electronic address eee, European association for the study of the L EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma. J Hepatol 69:182\u2013236","journal-title":"J Hepatol"},{"key":"10371_CR83","doi-asserted-by":"crossref","unstructured":"Rimola J, Darnell A, Belmonte E et al (2020) Does transient arterial-phase respiratory-motion-related artifact impact on diagnostic performance? An intra-patient comparison of extracellular gadolinium versus gadoxetic acid. Eur Radiol 30:6694\u20136701","DOI":"10.1007\/s00330-020-07039-6"},{"key":"10371_CR84","doi-asserted-by":"publisher","first-page":"4037","DOI":"10.1007\/s00261-019-02202-0","volume":"44","author":"KC Sim","year":"2019","unstructured":"Sim KC, Park BJ, Han NY, Sung DJ, Kim MJ, Han YE (2019) Effects of gadoxetic acid on image quality of arterial multiphase magnetic resonance imaging of liver: comparison study with gadoteric acid-enhanced MRI. Abdom Radiol (NY) 44:4037\u20134047","journal-title":"Abdom Radiol (NY)"},{"key":"10371_CR85","doi-asserted-by":"crossref","unstructured":"Frydrychowicz A, Lubner MG, Brown JJ et al (2012) Hepatobiliary MR imaging with gadolinium-based contrast agents. J Magn Reson Imaging 35:492\u2013511","DOI":"10.1002\/jmri.22833"},{"key":"10371_CR86","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1007\/s00330-004-2236-1","volume":"14","author":"P Reimer","year":"2004","unstructured":"Reimer P, Schneider G, Schima W (2004) Hepatobiliary contrast agents for contrast-enhanced MRI of the liver: properties, clinical development and applications. Eur Radiol 14:559\u2013578","journal-title":"Eur Radiol"},{"key":"10371_CR87","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1002\/jmri.25345","volume":"45","author":"JK Duncan","year":"2017","unstructured":"Duncan JK, Ma N, Vreugdenburg TD, Cameron AL, Maddern G (2017) Gadoxetic acid-enhanced MRI for the characterization of hepatocellular carcinoma: a systematic review and meta-analysis. J Magn Reson Imaging 45:281\u2013290","journal-title":"J Magn Reson Imaging"},{"key":"10371_CR88","doi-asserted-by":"crossref","unstructured":"Sugimoto K, Moriyasu F, Saito K et al (2012) Comparison of Kupffer-phase Sonazoid-enhanced sonography and hepatobiliary-phase gadoxetic acid-enhanced magnetic resonance imaging of hepatocellular carcinoma and correlation with histologic grading. J Ultrasound Med 31:529\u2013538","DOI":"10.7863\/jum.2012.31.4.529"},{"key":"10371_CR89","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1097\/RLI.0b013e31805f2682","volume":"42","author":"R Watanabe","year":"2007","unstructured":"Watanabe R, Matsumura M, Munemasa T, Fujimaki M, Suematsu M (2007) Mechanism of hepatic parenchyma-specific contrast of microbubble-based contrast agent for ultrasonography: microscopic studies in rat liver. Invest Radiol 42:643\u2013651","journal-title":"Invest Radiol"},{"key":"10371_CR90","doi-asserted-by":"crossref","unstructured":"Tochio H, Sugahara M, Imai Y et al (2015) Hyperenhanced rim surrounding liver metastatic tumors in the postvascular phase of sonazoid-enhanced ultrasonography: a histological indication of the presence of Kupffer cells. Oncology 89(Suppl 2):33\u201341","DOI":"10.1159\/000440629"}],"container-title":["European Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00330-023-10371-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00330-023-10371-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00330-023-10371-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,11]],"date-time":"2024-06-11T10:10:24Z","timestamp":1718100624000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00330-023-10371-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,22]]},"references-count":90,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2024,6]]}},"alternative-id":["10371"],"URL":"https:\/\/doi.org\/10.1007\/s00330-023-10371-2","relation":{},"ISSN":["1432-1084"],"issn-type":[{"value":"1432-1084","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,22]]},"assertion":[{"value":"16 June 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 August 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 August 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 November 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The scientific guarantor of this publication is Prof. Christoph F Dietrich.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Guarantor"}},{"value":"Paul S. Sidhu was Principal Investigator for Phase 3 clinical trials for SonoVue and Sonazoid.Paul S. Sidhu has received lecture fees from GE healthcare, Philips, Siemens, Bracco, Samsung.Paul S. Sidhu has received research support from GE and SamsungChristoph F Dietrich was Principal Investigator for Phase 3 clinical trials for SonoVue.Christoph F Dietrich has received lecture fees from Bracco, Siemens, Mindray, Hitachi, JAZZ, and Janssen.Christoph F Dietrich and Paul S. Sidhu has received research support from Mindray, GE Healthcare, Fresenius, Youkey, and Schallware.The other authors of this manuscript declare no relationships with any companies, whose products or services may be related to the subject matter of the article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"No complex statistical methods were necessary for this paper.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Statistics and biometry"}},{"value":"Written informed consent was not required for this study because it is a meta-analysis.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"Institutional Review Board approval was not required because it is a meta-analysis.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"No study subjects or cohorts have been previously reported.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Study subjects or cohorts overlap"}},{"value":"\u2022 Performed at one institution","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Methodology"}}]}}